MedTrace Logo

Obstacles to Deprescribing Among French Patients Over 75 Years of Age Treated in the Geriatric Hospital Network

NCT05327634 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2024-09-19

No results posted yet for this study

Summary

The aim of this study is to highlight action guidelines to encourage acceptance of deprescribing in people over 75 years of age: training, therapeutic education, post-prescription follow-up, specific patient pathways, specific consultations or even the integration of an advanced practice nurse in this process.

Conditions

  • Medication Abuse

Interventions

OTHER

self-questionnaire

Prospective study on patients aged 75 and over, hospitalised in geriatric short stay or geriatric rehabilitation units

Sponsors & Collaborators

  • Hôpital NOVO

    lead OTHER

Principal Investigators

  • Christophe Antoniazzi · Hospital René Dubos

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2023-01-25
Completion
2023-01-25

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05327634 on ClinicalTrials.gov